Illumina urges shareholders to reject Carl Icahn's board nominees as proxy fight heats up

March 30, 2023
Illumina told shareholders that Carl Icahn's board nominees would "threaten the progress" of the biotech company's core business.

from Health and Science https://ift.tt/qO8Kteu
https://ift.tt/TPaLrUg
https://ift.tt/gVpuYFN

Leave a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.